Inotiv, Inc. — Director's Dealing 2012

Oct 16, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOANALYTICAL SYSTEMS INC (BASI)
CIK: 0000720154
Period of Report: 2012-10-15

Reporting Person: Lemke Jacqueline M (Intrm Pres & CEO, CFO & VP Fin)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-10-15	Option to Purchase Common Shares	$1.32	A	50000	Acquired	2022-10-15	Common Shares (50000)	Direct

Footnotes

F1: The options vest and become exercisable upon achievement by Ms. Lemke of certain financial performance goals established by the Company's Board of Directors. The Board of Directors will determine if Ms. Lemke has met such financial performance goals no later than February 4, 2013.